166 related articles for article (PubMed ID: 12962909)
1. Apolipoprotein E -491 promoter polymorphism is an independent risk factor for Alzheimer's disease in the Chinese population.
Yang JD; Feng GY; Zhang J; Cheung J; St Clair D; He L; Ichimura K
Neurosci Lett; 2003 Oct; 350(1):25-8. PubMed ID: 12962909
[TBL] [Abstract][Full Text] [Related]
2. APOE and APOC1 promoter polymorphisms and the risk of Alzheimer disease in African American and Caribbean Hispanic individuals.
Tycko B; Lee JH; Ciappa A; Saxena A; Li CM; Feng L; Arriaga A; Stern Y; Lantigua R; Shachter N; Mayeux R
Arch Neurol; 2004 Sep; 61(9):1434-9. PubMed ID: 15364690
[TBL] [Abstract][Full Text] [Related]
3. The -491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: independent risk and linkage disequilibrium with the known APOE polymorphism.
Town T; Paris D; Fallin D; Duara R; Barker W; Gold M; Crawford F; Mullan M
Neurosci Lett; 1998 Aug; 252(2):95-8. PubMed ID: 9756330
[TBL] [Abstract][Full Text] [Related]
4. APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population.
Zurutuza L; Verpillat P; Raux G; Hannequin D; Puel M; Belliard S; Michon A; Pothin Y; Camuzat A; Penet C; Martin C; Brice A; Campion D; Clerget-Darpoux F; Frebourg T
Eur J Hum Genet; 2000 Sep; 8(9):713-6. PubMed ID: 10980578
[TBL] [Abstract][Full Text] [Related]
5. Association of APOE promoter but not A2M polymorphisms with risk of developing Alzheimer's disease.
Halimi G; Duplan L; Bideau C; Iniesta D; Berthézène P; Oddoze C; Verdier JM; Michel B; Bergé-Lefranc JL
Neuroreport; 2000 Nov; 11(16):3599-601. PubMed ID: 11095526
[TBL] [Abstract][Full Text] [Related]
6. Association between selected cholesterol-related gene polymorphisms and Alzheimer's disease in a Turkish cohort.
Guven G; Vurgun E; Bilgic B; Hanagasi H; Gurvit H; Ozer E; Lohmann E; Erginel-Unaltuna N
Mol Biol Rep; 2019 Apr; 46(2):1701-1707. PubMed ID: 30684189
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of APOE and LRP genes in Brazilian individuals with Alzheimer disease.
Bahia VS; Kok F; Marie SN; Shinjo SO; Caramelli P; Nitrini R
Alzheimer Dis Assoc Disord; 2008; 22(1):61-5. PubMed ID: 18317248
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region.
Chartier-Harlin MC; Parfitt M; Legrain S; Pérez-Tur J; Brousseau T; Evans A; Berr C; Vidal O; Roques P; Gourlet V
Hum Mol Genet; 1994 Apr; 3(4):569-74. PubMed ID: 8069300
[TBL] [Abstract][Full Text] [Related]
9. ApoE -491A/T promoter polymorphism is not an independent risk factor, but associated with the epsilon4 allele in Hungarian Alzheimer's dementia population.
Juhász A; Palotás A; Janka Z; Rimanóczy A; Palotás M; Bódi N; Boda K; Zana M; Vincze G; Kálmán J
Neurochem Res; 2005 May; 30(5):591-6. PubMed ID: 16176061
[TBL] [Abstract][Full Text] [Related]
10. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease.
Cui T; Zhou X; Jin W; Zheng F; Cao X
Chin Med J (Engl); 2000 Apr; 113(4):340-4. PubMed ID: 11775232
[TBL] [Abstract][Full Text] [Related]
11. [Apolipoprotein E genotype as a risk factor in Japanese patients with early-onset and late-onset Alzheimer's disease].
Shimada K; Yasuda M; Maeda K
Seishin Shinkeigaku Zasshi; 1997; 99(8):575-87. PubMed ID: 9369084
[TBL] [Abstract][Full Text] [Related]
12. [A study on the relation between the apolipoprotein E promoter -427C/T polymorphism and Alzheimer's disease].
Tang GM; Zhang MY; Jiang SD; Qian YP; Wang DX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Jun; 20(3):244-6. PubMed ID: 12778455
[TBL] [Abstract][Full Text] [Related]
13. Lack of independent associations of apolipoprotein E promoter and intron 1 polymorphisms with Alzheimer's disease.
Rebeck GW; Cheung BS; Growdon WB; Deng A; Akuthota P; Locascio J; Greenberg SM; Hyman BT
Neurosci Lett; 1999 Sep; 272(3):155-8. PubMed ID: 10505604
[TBL] [Abstract][Full Text] [Related]
14. The algorithm for Alzheimer risk assessment based on APOE promoter polymorphisms.
Limon-Sztencel A; Lipska-Ziętkiewicz BS; Chmara M; Wasag B; Bidzan L; Godlewska BR; Limon J
Alzheimers Res Ther; 2016 May; 8(1):19. PubMed ID: 27193889
[TBL] [Abstract][Full Text] [Related]
15. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
[TBL] [Abstract][Full Text] [Related]
16. Contribution of APOE promoter polymorphisms to Alzheimer's disease risk.
Lambert JC; Araria-Goumidi L; Myllykangas L; Ellis C; Wang JC; Bullido MJ; Harris JM; Artiga MJ; Hernandez D; Kwon JM; Frigard B; Petersen RC; Cumming AM; Pasquier F; Sastre I; Tienari PJ; Frank A; Sulkava R; Morris JC; St Clair D; Mann DM; Wavrant-DeVrièze F; Ezquerra-Trabalon M; Amouyel P; Hardy J; Haltia M; Valdivieso F; Goate AM; Pérez-Tur J; Lendon CL; Chartier-Harlin MC
Neurology; 2002 Jul; 59(1):59-66. PubMed ID: 12105308
[TBL] [Abstract][Full Text] [Related]
17. The -491 A/T polymorphism in the regulatory region of the apolipoprotein E gene and early-onset Alzheimer's disease.
Roks G; Cruts M; Bullido MJ; Backhovens H; Artiga MJ; Hofman A; Valdivieso F; Van Broeckhoven C; Van Duijn CM
Neurosci Lett; 1998 Dec; 258(2):65-8. PubMed ID: 9875528
[TBL] [Abstract][Full Text] [Related]
18. Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease.
Wang JC; Kwon JM; Shah P; Morris JC; Goate A
Neurology; 2000 Dec; 55(11):1644-9. PubMed ID: 11113217
[TBL] [Abstract][Full Text] [Related]
19. Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals.
Helisalmi S; Hiltunen M; Valonen P; Mannermaa A; Koivisto AM; Lehtovirta M; Ryynänen M; Soininen H
J Neurol; 1999 Sep; 246(9):821-4. PubMed ID: 10525981
[TBL] [Abstract][Full Text] [Related]
20. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
